𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of transarterial chemoembolization for hepatocellular carcinoma before liver transplantation with special consideration of tumor necrosis

✍ Scribed by André Schaudt; Susanne Kriener; Wolfram Schwarz; Christoph Wullstein; Stephan Zangos; Thomas Vogl; Arianeb Mehrabi; Hamidreza Fonouni; Wolf O. Bechstein; Markus Golling

Book ID
115092069
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
217 KB
Volume
23
Category
Article
ISSN
0902-0063

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of two techniques of transart
Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: A case-control study
✍ Sébastien Dharancy; Jeanne Boitard; Thomas Decaens; Géraldine Sergent; Emmanuel 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

Supraselective transarterial chemoembolization (STACE) more efficiently targets chemotherapy delivered via the feeding arterial branches of the tumor than does conventional transarterial chemoembolization (TACE). However, the hypothesis of its greater efficacy compared with the latter is subject to

Impact of pretransplantation transarteri
Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma
✍ Thomas Decaens; Françoise Roudot-Thoraval; Solange Bresson-Hadni; Carole Meyer; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

The actual impact of transarterial chemoembolization before liver transplantation (LT) for hepatocellular carcinoma (HCC) on patient survival and HCC recurrence is not known. Between 1985 and 1998, 479 patients with HCC in 14 French centers were evaluated for LT. Among these 479 patients, this case-

Tumor recurrence following liver transpl
Tumor recurrence following liver transplantation for hepatocellular carcinoma: Role of tumor proliferation status
✍ Aileen E. Marshall; Simon M. Rushbrook; Sarah L. Vowler; Christopher R. Palmer; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB

The selection of patients with hepatocellular carcinoma for liver transplantation is currently based on the size and number of tumors to minimize the risk of recurrence. These criteria measure tumor bulk but may not reflect tumor behavior accurately. A biological marker of tumor behavior could aid w